AUG 31, 2017 12:38 PM PDT

Two Immune Cell Types Accidentally Promote Heart Disease

WRITTEN BY: Kara Marker

Prescribing drugs that lower “bad” cholesterol is a common approach to treating heart disease, but scientists from the Karolinska Institute think there may be another solution.

Histopathology of atherosclerosis. Credit: Wikimedia User Pathos

Atherosclerosis, a disease characterized by the development of plaques in blood vessels that impede blood flow, is a common marker of heart disease. Immune cells called T cells and dendritic cells are regular occupiers of atherosclerotic plaques, where a collection of these cells and other debris floating through blood vessels ultimately pack together and block the flow of oxygenated blood to the heart. By targeting these immune cells, Karolinska Institute scientists believe they could develop a method for treating heart disease completely separate from techniques focused on lowering low-density lipoprotein (LDL), AKA “bad” cholesterol.

The main “ingredient” of this new technique is a protein called PCSK9 (proprotein convertase subtilisin kexin 9). PCSK9 proteins degrade LDL receptors, which results in increased amounts of LDL. Thus, PCSK9 inhibitors are prescribed to lower LDL cholesterol. But there’s yet another use for PCSK9 inhibitors.

The scientists needed to find a way to inhibit immune cells promoting the formation of atherosclerotic plaques without suppressing the entire immune system. So, they needed to know what specifically activates the T cells and dendritic cells found in atherosclerotic plaques. They discovered two key players: PCSK9 and oxidized LDL.

When LDL becomes oxidized, a modification is made to the lipoprotein that promotes its interaction with and uptake by macrophages, making oxidized LDL a clear marker for cardiovascular disease.

Researchers collected T cells from carotid arteries from people with atherosclerosis and from healthy individuals. Dendritic cells were taken from human peripheral blood. They combined dendritic cells with oxidized LDL before adding in T cells.

They found that oxidized LDL both triggered production of PCSK9 proteins and induced dendritic cell maturation and T cell activation into helper cells. However, inhibiting PCSK9 reversed the effects.

“This changed a pro-inflammatory profile into an anti-inflammatory state that is potentially anti-atherosclerotic,” explained lead author Prof Johan Frostegård. “The benefits of PCSK9 inhibition extend beyond lowering LDL cholesterol.”

Source: Methods in Molecular Biology, European Society of Cardiology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 18, 2021
Cardiology
Searching for New Cardiovascular Biomarkers
MAR 18, 2021
Searching for New Cardiovascular Biomarkers
Do you want to know what the best medicine for cardiovascular health is? It isn't some heart-shaped pill with some m ...
MAR 29, 2021
Cardiology
Learning More About How Stress Breaks the Heart
MAR 29, 2021
Learning More About How Stress Breaks the Heart
Scientists are learning more about what causes a real phenomenon known as broken heart syndrome, or stress-related cardi ...
MAY 03, 2021
Health & Medicine
Want to Become a Better Runner? Get More Sleep.
MAY 03, 2021
Want to Become a Better Runner? Get More Sleep.
Want to get the most out of your workout routine? Don't skimp on sleep, especially if you're focusing on enduran ...
MAY 19, 2021
Immunology
Intestinal Macrophages Promote Chronic Inflammation in Obesity
MAY 19, 2021
Intestinal Macrophages Promote Chronic Inflammation in Obesity
A research group from Switzerland hypothesized that immune cells in the gut (gastrointestinal tract) must trigger chroni ...
JUN 15, 2021
Cardiology
A Common Thread Among 20% of Sudden Cardiac Deaths
JUN 15, 2021
A Common Thread Among 20% of Sudden Cardiac Deaths
It's estimated that 450,000 Americans die from sudden heart conditions, and in about one in ten cases, the cause is unex ...
AUG 15, 2021
Neuroscience
Cholesterol in the Brain Linked to Alzheimer's Plaques
AUG 15, 2021
Cholesterol in the Brain Linked to Alzheimer's Plaques
Cholesterol levels in the brain tightly regulate the production of amyloid-beta plaques in the brain, a key feature of A ...
Loading Comments...